Today: 16 April 2026
Moody’s stock price holds near $418 in premarket after AI jitters hammer ratings peers
11 February 2026
1 min read

Moody’s stock price holds near $418 in premarket after AI jitters hammer ratings peers

New York, Feb 11, 2026, 06:46 ET — Premarket

  • Moody’s dipped another 0.1% before the bell, following Tuesday’s sharp 6.8% drop.
  • S&P Global’s downbeat 2026 profit outlook triggered a broader sector selloff, dragging shares lower.
  • Next week, investors will be watching Moody’s earnings for clues on issuance trends and appetite for analytics.

Shares of Moody’s Corporation (NYSE:MCO) slipped 0.1% to $418.49 ahead of Wednesday’s open. The stock had closed Tuesday at $418.96, capping a sharp 6.8% decline.

Financial data and ratings firms, usually seen as reliable profit generators, are in focus after the recent pullback. Now, attention is on whether emerging AI tools might start eroding the pricing power these analytics and research products command.

Moody’s faces its results next week with little leeway for a cautious tone. Traders want fresh clues on the pace of debt issuance—the lifeblood for ratings fees—and are watching to see if clients stick with analytics subscriptions at the current rate.

Rival S&P Global threw out a 2026 adjusted earnings-per-share forecast between $19.40 and $19.65, missing analysts’ consensus of $19.94, LSEG numbers show. The stock nosedived 9.7%, touching a low not seen in over two years.

The group took a hit. Moody’s sank 6.8% by Tuesday’s close; Verisk finished almost 5% lower, and Nasdaq stumbled 4.4%. Investors cut back across the sector.

S&P’s top brass doesn’t buy the story that AI is all downside. “We see AI really is a net tailwind for the business,” CEO Martina Cheung said to analysts during the company’s earnings call. The Motley Fool

Moody’s business comes down to two main levers: ratings fees—those swing up or down with capital markets—and steady income off its data and analytics products. When deals stall, revenue tied to transactions often disappears quickly. Subscription revenue hangs on longer, but that’s not bulletproof; clients can trim headcount and shrink those lines too.

Credit markets saw fresh action this week as both Moody’s and S&P lowered Stellantis to the bottom rung of investment-grade, just a notch shy of “junk”, pointing to softer profitability and cash-flow outlooks. Reuters

Uncertainty continues to dictate the equity tape here, rather than any isolated downgrade. Should investors start to treat the AI threat as more than just noise — or if new issuance keeps dragging — Moody’s might have to grapple with a tougher valuation reset, and that’s before its report lands.

Mark Feb. 18 on the calendar—Moody’s is set to report fourth-quarter and full-year results, with the conference call scheduled for 9:00 a.m. ET.

Stock Market Today

  • Soybeans Rally Midweek on Strong Demand and Export Sales Outlook
    April 16, 2026, 1:45 AM EDT. Soybeans gained 9 to 11 cents on Wednesday, with the national average cash price rising to $11.01 3/4. Soymeal and soy oil futures also increased, reflecting positive market momentum. Traders anticipate USDA's weekly export sales report Thursday, expecting 200,000 to 600,000 metric tons of old crop beans sold, with new crop sales forecast up to 100,000 MT. NOPA reported a record March crush of 226.16 million bushels, though slightly below estimates. Soybean oil stocks declined 1.97% since February but remain 36% higher year-on-year. May and July soybean contracts closed higher, supported by strong demand signals and steady domestic processing.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 16.04.2026

16 April 2026
LIVEMarkets rolling coverageStarted: April 16, 2026, 12:00 AM EDTUpdated: April 16, 2026, 1:54 AM EDT Soybeans Rally Midweek on Strong Demand and Export Sales Outlook April 16, 2026, 1:45 AM EDT. Soybeans gained 9 to 11 cents on Wednesday, with the national average cash price rising to $11.01 3/4. Soymeal and soy oil futures also increased, reflecting positive market momentum. Traders anticipate USDA's weekly export sales report Thursday, expecting 200,000 to 600,000 metric tons of old crop beans sold, with new crop sales forecast up to 100,000 MT. NOPA reported a record March crush of 226.16 million bushels, though slightly
Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Quince Therapeutics (QNCX) stock price jumps in premarket as strategic review keeps deal talk alive
Previous Story

Quince Therapeutics (QNCX) stock price jumps in premarket as strategic review keeps deal talk alive

QVC Group stock (QVCGA) plunges on creditor-talks report as bankruptcy risk comes into view
Next Story

QVC Group stock (QVCGA) plunges on creditor-talks report as bankruptcy risk comes into view

Go toTop